Annual D&A:
$1.80M+$93.00K(+5.46%)Summary
- As of today, APLS annual D&A is $1.80 million, with the most recent change of +$93.00 thousand (+5.46%) on December 31, 2024.
- During the last 3 years, APLS annual D&A has risen by +$305.00 thousand (+20.44%).
- APLS annual D&A is now at all-time high.
Performance
APLS Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$339.00K-$107.00K(-23.99%)Summary
- As of today, APLS quarterly D&A is $339.00 thousand, with the most recent change of -$107.00 thousand (-23.99%) on September 30, 2025.
- Over the past year, APLS quarterly D&A has dropped by -$118.00 thousand (-25.82%).
- APLS quarterly D&A is now -30.82% below its all-time high of $490.00 thousand, reached on December 31, 2023.
Performance
APLS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.68M-$118.00K(-6.57%)Summary
- As of today, APLS TTM D&A is $1.68 million, with the most recent change of -$118.00 thousand (-6.57%) on September 30, 2025.
- Over the past year, APLS TTM D&A has dropped by -$162.00 thousand (-8.80%).
- APLS TTM D&A is now -8.80% below its all-time high of $1.84 million, reached on September 30, 2024.
Performance
APLS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
APLS Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +5.5% | -25.8% | -8.8% |
| 3Y3 Years | +20.4% | -5.0% | +16.9% |
| 5Y5 Years | +201.8% | +7.6% | +111.1% |
APLS Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +20.9% | -30.8% | at low | -8.8% | +16.9% |
| 5Y | 5-Year | at high | +201.8% | -30.8% | +23.7% | -8.8% | +111.1% |
| All-Time | All-Time | at high | >+9999.0% | -30.8% | +199.5% | -8.8% | +1382.3% |
APLS Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $339.00K(-24.0%) | $1.68M(-6.6%) |
| Jun 2025 | - | $446.00K(0.0%) | $1.80M(-0.2%) |
| Mar 2025 | - | $446.00K(-0.2%) | $1.80M(+0.1%) |
| Dec 2024 | $1.80M(+5.5%) | $447.00K(-2.2%) | $1.80M(-2.3%) |
| Sep 2024 | - | $457.00K(+1.8%) | $1.84M(+2.9%) |
| Jun 2024 | - | $449.00K(+1.1%) | $1.79M(+2.2%) |
| Mar 2024 | - | $444.00K(-9.4%) | $1.75M(+2.6%) |
| Dec 2023 | $1.70M(+14.6%) | $490.00K(+21.0%) | $1.70M(+3.8%) |
| Sep 2023 | - | $405.00K(-1.2%) | $1.64M(+3.0%) |
| Jun 2023 | - | $410.00K(+2.8%) | $1.59M(+4.5%) |
| Mar 2023 | - | $399.00K(-6.8%) | $1.53M(+2.6%) |
| Dec 2022 | $1.49M(-0.3%) | $428.00K(+19.9%) | $1.49M(+3.6%) |
| Sep 2022 | - | $357.00K(+4.4%) | $1.44M(+6.1%) |
| Jun 2022 | - | $342.00K(-5.0%) | $1.35M(-7.3%) |
| Mar 2022 | - | $360.00K(-4.3%) | $1.46M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.49M(+73.7%) | $376.00K(+37.2%) | $1.49M(+6.9%) |
| Sep 2021 | - | $274.00K(-38.8%) | $1.40M(-2.9%) |
| Jun 2021 | - | $448.00K(+13.7%) | $1.44M(+29.3%) |
| Mar 2021 | - | $394.00K(+40.7%) | $1.11M(+29.3%) |
| Dec 2020 | $859.00K(+44.3%) | $280.00K(-11.1%) | $859.00K(+8.1%) |
| Sep 2020 | - | $315.00K(+158.2%) | $794.90K(+27.6%) |
| Jun 2020 | - | $122.00K(-14.1%) | $623.20K(-0.2%) |
| Mar 2020 | - | $142.00K(-34.2%) | $624.20K(+4.8%) |
| Dec 2019 | $595.40K(+4903.4%) | $215.90K(+50.7%) | $595.40K(+56.9%) |
| Sep 2019 | - | $143.30K(+16.5%) | $379.50K(+60.7%) |
| Jun 2019 | - | $123.00K(+8.7%) | $236.20K(+108.7%) |
| Mar 2019 | - | $113.20K(-45.7%) | $113.20K(-45.7%) |
| Mar 2018 | - | $208.60K | $208.60K |
| Dec 2017 | $11.90K(+80.3%) | - | - |
| Dec 2014 | $6600.00(+4.8%) | - | - |
| Dec 2013 | $6300.00 | - | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual D&A?
- What is the all-time high annual D&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Apellis Pharmaceuticals, Inc. TTM D&A?
- What is the all-time high TTM D&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual D&A?
The current annual D&A of APLS is $1.80M
What is the all-time high annual D&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual D&A is $1.80M
What is Apellis Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, APLS annual D&A has changed by +$93.00K (+5.46%)
What is Apellis Pharmaceuticals, Inc. quarterly D&A?
The current quarterly D&A of APLS is $339.00K
What is the all-time high quarterly D&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly D&A is $490.00K
What is Apellis Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, APLS quarterly D&A has changed by -$118.00K (-25.82%)
What is Apellis Pharmaceuticals, Inc. TTM D&A?
The current TTM D&A of APLS is $1.68M
What is the all-time high TTM D&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high TTM D&A is $1.84M
What is Apellis Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, APLS TTM D&A has changed by -$162.00K (-8.80%)